litlas
Log inCreate account

William W. Busse

Active 1972–2025

Also published as
William W Busse · WILLIAM W. BUSSE · WIlliam W Busse
294
Papers
67,301
Citations
136
h-index
285
i10-index

Citations

Citations per year for William W. Busse1973: 1 citations1974: 1 citations1975: 1 citations1977: 2 citations1978: 1 citations1981: 3 citations1983: 4 citations1984: 4 citations1985: 2 citations1986: 5 citations1987: 2 citations1988: 1 citations1989: 8 citations1990: 12 citations1991: 13 citations1992: 26 citations1993: 33 citations1994: 43 citations1995: 44 citations1996: 64 citations1997: 108 citations1998: 140 citations1999: 171 citations2000: 214 citations2001: 222 citations2002: 266 citations2003: 307 citations2004: 260 citations2005: 304 citations2006: 347 citations2007: 296 citations2008: 377 citations2009: 383 citations2010: 445 citations2011: 511 citations2012: 543 citations2013: 502 citations2014: 577 citations2015: 582 citations2016: 573 citations2017: 617 citations2018: 506 citations2019: 2,053 citations2020: 2,192 citations2021: 1,962 citations2022: 1,624 citations2023: 1,136 citations2024: 1,554 citations2025: 807 citations2026: 11 citations1976: no citations, so this year is not shown1979–1980: no citations, so these years are not shown1982: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,913 citing papers, 21.8% of this breakdownUnited Kingdom: 2,111 citing papers, 9.4% of this breakdownChina: 1,123 citing papers, 5% of this breakdownItaly: 1,078 citing papers, 4.8% of this breakdownGermany: 956 citing papers, 4.3% of this breakdownCanada: 952 citing papers, 4.2% of this breakdownFrance: 829 citing papers, 3.7% of this breakdownAustralia: 820 citing papers, 3.7% of this breakdownNetherlands: 771 citing papers, 3.4% of this breakdownJapan: 707 citing papers, 3.1% of this breakdownSpain: 681 citing papers, 3% of this breakdownSweden: 601 citing papers, 2.7% of this breakdown
0%21.8%Other 30.9%

Institutions

Fields

  • Medicine78.9%
  • Immunology and Microbiology7%
  • Biochemistry, Genetics and Molecular Biology6.3%
  • Environmental Science2%
  • Neuroscience1.4%
  • Health Professions0.9%
  • Other3.5%

Topics

  • Asthma and respiratory diseases22.6%
  • Allergic Rhinitis and Sensitization7.2%
  • Respiratory and Cough-Related Research5.3%
  • IL-33, ST2, and ILC Pathways4.5%
  • Chronic Obstructive Pulmonary Disease (COPD) Research3.5%
  • Dermatology and Skin Diseases3%
  • Other53.9%

Coauthors

All papers

Open in search
  1. Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

    Authors: Mario Castro, Jonathan Corren, Ian Pavord, Jorge Máspero, Sally E. Wenzel, Klaus F. Rabe, William W. Busse, Linda Ford, Lawrence Sher, J. Mark FitzGerald, Constance H. Katelaris, Yuji Tohda, Bingzhi Zhang, Heribert Staudinger, Gianluca Pirozzi, Nikhil Amin, Marcella Ruddy, Bolanle Akinlade, Asif Khan, Jingdong Chao, Renata Martincova, Neil M.H. Graham, Jennifer D. Hamilton, Brian N. Swanson, Neil Stahl, George D. Yancopoulos, Ariel Teper - New England Journal of Medicine 2018 cited by 1,929

  2. Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

    Authors: J. Mark FitzGerald, Eugene R. Bleecker, Parameswaran Nair, Stephanie Korn, Ken Ohta, Marek Lommatzsch, Gary T. Ferguson, William W. Busse, Peter Barker, Stephanie Sproule, Geoffrey Gilmartin, Viktoría Werkström, Magnus Aurivillius, Mitchell Goldman - The Lancet 2016 cited by 1,379

  3. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*

    Authors: Jean Bousquet, N. Khaltaev, Álvaro A. Cruz, Judah A. Denburg, Wytske J. Fokkens, Alkis Togias, Torsten Zuberbier, Carlos E. Baena‐Cagnani, Giorgio Walter Canonica, Chris van Weel, Ioana Agache, N Aït-Khaled, Claus Bachert, Michael S. Blaiss, С. Бонини, Louis‐Philippe Boulet, Philippe‐Jean Bousquet, Paulo Augusto Moreira Camargos, K.‐H. Carlsen, Y. Chen, Adnan Čustović, Ronald Dahl, Pascal Demoly, H. Douagui, S. R. Durham, Roy Gerth van Wijk, O. Kalayci, Michael Kaliner, Y.‐Y. Kim, M. L. Kowalski, Piotr Kuna, L. T. T. Le, Catherine Lemière, Junjie Li, Richard F. Lockey, S. Mavale‐Manuel, Eli O. Meltzer, Yousser Mohammad, Joaquim Mullol, Robert M. Naclerio, Robyn E. O’Hehir, Ken Ohta, S. Ouedraogo, S. Palkonen, Nikolaos G. Papadopoulos, Giovanni Passalacqua, R. Pawankar, Todor A. Popov, Klaus F. Rabe, J. Rosado‐Pinto, G. K. Scadding, F. Estelle R. Simons, Е. Тоскала, E. Valovirta, Paul Van Cauwenberge, De Yun Wang, Magnus Wickman, Barbara P. Yawn, Arzu Yorgancıoğlu, Osman Yusuf, Heather J. Zar, I. Annesi‐Maesano, E. D. Bateman, A. Ben Kheder, Daniel A. Boakye, J. Bouchard, Peter Burney, William W. Busse, Moira Chan‐Yeung, Niels H. Chavannes, А. Г. Чучалин, William K. Dolen, R. Emuzyte, L. Grouse, Marc Humbert, Claire Jackson, Sebastian L. Johnston, Paul K. Keith, James P. Kemp, J.‐M. Klossek, Désirée Larenas‐Linnemann, Brian J. Lipworth, Malo Jl, Gailen D. Marshall, Charles K. Naspitz, K Nékám, B. Niggemann, Ewa Niżankowska‐Mogilnicka, Yoshitaka Okamoto, Marco Orrù, P. Potter, David Price, Stuart Stoloff, Olivier Vandenplas, Giovanni Viegi, Dennis Williams - Allergy 2008 cited by 4,703

  4. An expert consensus framework for asthma remission as a treatment goal

    Authors: Andrew Menzies‐Gow, Mona Bafadhel, William W. Busse, Thomas B. Casale, Janwillem Kocks, Ian Pavord, Stanley J. Szefler, Prescott G. Woodruff, Alexander de Giorgio-Miller, Frank Trudo, Malin Fagerås, Christopher S. Ambrose - Journal of Allergy and Clinical Immunology 2019 cited by 407

  5. Type 2 immunity in the skin and lungs

    Authors: Cezmi A. Akdiş, Peter D. Arkwright, Marie‐Charlotte Brüggen, William W. Busse, Massimo Gadina, Emma Guttman‐Yassky, Kenji Kabashima, Yasutaka Mitamura, Laura Vian, Jianni Wu, Óscar Palomares - Allergy 2020 cited by 552

  6. Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program

    Authors: Wendy C. Moore, Deborah A. Meyers, Sally E. Wenzel, W. Gerald Teague, Huashi Li, Xingnan Li, Ralph B. D’Agostino, Mario Castro, Douglas Curran‐Everett, Anne M. Fitzpatrick, Benjamin Gaston, Nizar N. Jarjour, Ronald L. Sorkness, William J. Calhoun, Kian Fan Chung, Suzy Comhair, Raed A. Dweik, Elliot Israel, Stephen P. Peters, William W. Busse, Serpil C. Erzurum, Eugene R. Bleecker - American Journal of Respiratory and Critical Care Medicine 2009 cited by 2,124

  7. An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations

    Authors: Helen K. Reddel, D. Robin Taylor, Eric D. Bateman, Louis‐Philippe Boulet, Homer A. Boushey, William W. Busse, Thomas B. Casale, Pascal Chanez, Paul Enright, Peter G. Gibson, Johan C. de Jongste, Huib A.M. Kerstjens, Stephen C. Lazarus, Mark L Levy, Paul M. O’Byrne, Martyn R Partridge, Ian Pavord, Malcolm R. Sears, Peter J. Sterk, Stuart Stoloff, Sean D. Sullivan, Stanley J. Szefler, Mike Thomas, Sally E. Wenzel - American Journal of Respiratory and Critical Care Medicine 2009 cited by 1,926

  8. Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis

    Authors: Wendy C. Moore, Annette T. Hastie, Xingnan Li, Huashi Li, William W. Busse, Nizar N. Jarjour, Sally E. Wenzel, Stephen P. Peters, Deborah A. Meyers, Eugene R. Bleecker - Journal of Allergy and Clinical Immunology 2013 cited by 591

  9. Exploring the Effects of Omalizumab in Allergic Asthma

    Authors: Nicola A. Hanania, Sally E. Wenzel, Karin Rosén, Hsin-Ju Hsieh, Sofia Mosesova, David F. Choy, Preeti Lal, Joseph R. Arron, Jeffrey M. Harris, William W. Busse - American Journal of Respiratory and Critical Care Medicine 2013 cited by 886

  10. Asthma Exacerbations: Pathogenesis, Prevention, and Treatment

    Authors: Jamee R. Castillo, Stephen P. Peters, William W. Busse - The Journal of Allergy and Clinical Immunology In Practice 2017 cited by 557

  11. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

    Authors: William W. Busse, Jonathan Corren, Bobby Q. Lanier, Margaret McAlary, Angel FowlerTaylor, Giovanni Della Cioppa, Andre van As, Niroo Gupta - Journal of Allergy and Clinical Immunology 2001 cited by 1,294

  12. Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation

    Authors: William W. Busse, Monica Kraft, Klaus F. Rabe, Yamo Deniz, Paul J. Rowe, Marcella Ruddy, Mario Castro - European Respiratory Journal 2021 cited by 160

  13. Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti–IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma

    Authors: William W. Busse, Stephen T. Holgate, Edward Kerwin, Yun Chon, JingYuan Feng, Joseph Lin, Shao‐Lee Lin - American Journal of Respiratory and Critical Care Medicine 2013 cited by 657

  14. Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial

    Authors: Daniel J. Jackson, Leonard B. Bacharier, Peter J. Gergen, Lisa Gagalis, Agustin Calatroni, Stephanie Wellford, Michelle A. Gill, Jeffrey R. Stokes, Andrew H. Liu, Rebecca S. Gruchalla, Robyn T. Cohen, Melanie Makhija, Gurjit K. Khurana Hershey, George O'connor, Jacqueline A. Pongracic, Michael G. Sherenian, Katherine Rivera‐Spoljaric, Edward M. Zoratti, Stephen J. Teach, Meyer Kattan, Cullen M. Dutmer, Hae Jin Kim, Carin Lamm, William J Sheehan, R. Max Segnitz, Kimberly A. Dill‐McFarland, Cynthia M. Visness, Patrice M. Becker, James E. Gern, Christine A. Sorkness, William W. Busse, Matthew C. Altman - The Lancet 2022 cited by 147

  15. Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy

    Authors: Nicola A. Hanania, Oral Alpan, Daniel L. Hamilos, John J. Condemi, Irmarie Reyes‐Rivera, Jin Zhu, Karin Rosén, Mark D. Eisner, Dennis A. Wong, William W. Busse - Annals of Internal Medicine 2011 cited by 550

  16. Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma

    Authors: Ian Pavord, Yamo Deniz, Jonathan Corren, Thomas B. Casale, J Mark FitzGerald, Kenji Izuhara, Nadia Daizadeh, Benjamin Ortiz, Robert R. Johnson, Sivan Harel, Michel Djandji, Ledia Goga, Nora Crikelair, Paul J. Rowe, William W. Busse - The Journal of Allergy and Clinical Immunology In Practice 2022 cited by 89

  17. Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia

    Authors: Michel Laviolette, David Gossage, Gail M. Gauvreau, Richard Leigh, Ron Olivenstein, Rohit Katial, William W. Busse, Sally E. Wenzel, Yanping Wu, Vivekananda Datta, Roland Kolbeck, Néstor A. Molfino - Journal of Allergy and Clinical Immunology 2013 cited by 508

  18. Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study

    Authors: Thomas B. Casale, Allan T. Luskin, William W. Busse, Robert S. Zeiger, Benjamin Trzaskoma, Ming Yang, Noelle M. Griffin, Bradley E. Chipps - The Journal of Allergy and Clinical Immunology In Practice 2018 cited by 276

  19. Associations between outdoor air pollutants and non-viral asthma exacerbations and airway inflammatory responses in children and adolescents living in urban areas in the USA: a retrospective secondary analysis

    Authors: Matthew C. Altman, Meyer Kattan, George O'connor, Ryan C. Murphy, Elizabeth Whalen, Petra LeBeau, Agustin Calatroni, Michelle A. Gill, Rebecca S. Gruchalla, Andrew H. Liu, Stephanie Lovinsky‐Desir, Jacqueline A. Pongracic, Carolyn M. Kercsmar, Gurjit K. Khurana Hershey, Edward M. Zoratti, Stephen J. Teach, Leonard B. Bacharier, Lisa M. Wheatley, Steve M. Sigelman, Peter J. Gergen, Alkis Togias, William W. Busse, James E. Gern, Daniel J. Jackson - The Lancet Planetary Health 2023 cited by 109

  20. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

    Authors: William W. Busse, Eugene R. Bleecker, J Mark FitzGerald, Gary T. Ferguson, Peter Barker, Stephanie Sproule, Richard F. Olsson, Ubaldo J. Martin, Mitchell Goldman, Anahí Yañez, Marcelo Fernández, Alberto Tolcachier, Juan Belloni, Jorge Taborda, Maria De Salvo, Jorge Máspero, Carlos Victorio, Miguel Chirino Navarta, Mónica Grilli, Pablo Alejandro Rodríguez, María Otaola, Victor Hugo Cambursano, Patricia Malamud, Ana Stok, German Arce, Osiris Roza, Fernando Scherbovsky, Pedro Carlos Elias, Maria Salazan Saez, Matthew Peters, Martin Phillips, John W. Upham, Peter G. Gibson, Francis Thien, John Aubrey Douglass, Paul Thomas, Philip G. Bardin, Dimitar Sajkov, Mark Hew, David Langton, Andreia Luisa Francisco Pez, Carlos Cézar Fritscher, Jorge Lima Hetzel, Waldo Mattos, Rafaël Stelmach, Martti Antila, Ana Luísa Godoy Fernandes, Hristo Metev, Yavor Ivanov, Aneliya Bogdanova, Ana Dancheva Markova, M Peneva, Rumyana Veselinova, Tatyana Petkova, Vanushka Petrova, E Shopova, Yuliya Ivanova, Rumyana Yotsova, Ginka Kirkova, Galina Petrova, Svetoslav Dachev, Kostadinka Sotirova, Mariyana Stoyanova, Oleg Yakov, Vanya Ilieva-Fartunova, Catherine Lemière, Michel Laviolette, William H. Yang, J Mark FitzGerald, Bonavuth Pek, William Patrick Killorn, Claude Poirier, Guy Chouinard, Lyle Melenka, Richard Leigh, Parameswaran Nair, Delbert Dorscheid, James G. Martin, Juana Pavie, Andres Rosenblut, Claudia Cartagena, Carlos Quilodran, Silvia Muñoz, Ivana Malkusova, Josef Veverka, Stanislav Holub, Jaroslav Mareš, Radovan Kozel, Daniela Kopecka, Vladimir Zindr, Pavel Cerva, Pascal Chanez, Arnaud Bourdin, Gilles Devouassoux, Camille Taillé, Frédéric de Blay, François Goupil, Christophe Leroyer, Delphine Gourcerol, T. Didi and 360 more - The Lancet Respiratory Medicine 2018 cited by 311

  21. Report from the National Institute of Allergy and Infectious Diseases workshop on “Atopic dermatitis and the atopic march: Mechanisms and interventions”

    Authors: Wendy F. Davidson, Donald Y.M. Leung, Lisa A. Beck, M. Cecilia Berin, Mark Boguniewicz, William W. Busse, Talal A. Chatila, Raif S. Geha, James E. Gern, Emma Guttman‐Yassky, Alan D. Irvine, Brian Kim, Heidi H. Kong, Gideon Lack, Kari C. Nadeau, Julie M. Schwaninger, Angela Simpson, Eric L. Simpson, Jonathan M. Spergel, Alkis Togias, Ulrich Wahn, Robert A. Wood, Judith A. Woodfolk, Steven F. Ziegler, Marshall Plaut - Journal of Allergy and Clinical Immunology 2019 cited by 201

  22. Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children

    Authors: William W. Busse, Wayne J. Morgan, Peter J. Gergen, Herman Mitchell, James E. Gern, Andrew H. Liu, Rebecca S. Gruchalla, Meyer Kattan, Stephen J. Teach, Jacqueline A. Pongracic, James F. Chmiel, Suzanne Steinbach, Augustin Calatroni, Alkis Togias, Katherine M. Thompson, Stanley J. Szefler, Christine A. Sorkness - New England Journal of Medicine 2011 cited by 870

  23. Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis

    Authors: William W. Busse, Sally E. Wenzel, Thomas B. Casale, J. Mark FitzGerald, Megan S. Rice, Nadia Daizadeh, Yamo Deniz, Naimish Patel, Sivan Harel, Paul J. Rowe, Neil M.H. Graham, Thomas G. O’Riordan, Ian Pavord - The Lancet Respiratory Medicine 2021 cited by 142

  24. Transcriptome networks identify mechanisms of viral and nonviral asthma exacerbations in children

    Authors: Matthew C. Altman, Michelle A. Gill, Elizabeth Whalen, Denise C. Babineau, Baomei Shao, Andrew H. Liu, Brett Jepson, Rebecca S. Gruchalla, George O'connor, Jacqueline A. Pongracic, Carolyn M. Kercsmar, Gurjit K. Khurana Hershey, Edward M. Zoratti, Christine Cole Johnson, Stephen J. Teach, Meyer Kattan, Leonard B. Bacharier, Avraham Beigelman, Steve M. Sigelman, Scott Presnell, James E. Gern, Peter J. Gergen, Lisa M. Wheatley, Alkis Togias, William W. Busse, Daniel J. Jackson - Nature Immunology 2019 cited by 183